The Effectiveness and Safety of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients With Stage III/IV: A Multicenter Study

Immune checkpoint inhibitors (ICIs) have been approved to treat patients with various cancer types, including lung cancer, in many countries. This study aims to investigate the effectiveness and safety of ICIs under different treatment conditions of non-small cell lung cancer patients. A population-...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Jason C., Nguyen, Phung-Anh, Chen, Yen-Tzu, Yang, Szu-Chun, Lin, Chien-Chung, Yang, Yi-Hsin, Lin, Yu-Chao, Hsia, Te-Chun, Hsieh, Hsing-Chun, Wu, Jia-Syuan, Chang, Chi-Pei, Feng, Yin-Hsun, Lin, Peng-Chan, Hsu, Ping-Chih, Tzeng, Huey-En, Chien, Shu-Chen, Chang, Wei-Chiao, Chang, Chih-Cheng, Yang, Hsuan-Chia, Lee, Chueh Ming, Lu, Christine Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293991/
https://www.ncbi.nlm.nih.gov/pubmed/34307141
http://dx.doi.org/10.3389/fonc.2021.671127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293991/
https://www.ncbi.nlm.nih.gov/pubmed/34307141
http://dx.doi.org/10.3389/fonc.2021.671127

Ejemplares similares